NCT05198648

Brief Summary

Myocardial injury after noncardiac surgery is significantly related to postoperative 30-day mortality. Trigeminal cardiac reflex is one of the main causes of perioperative cardiac emergency. Therefore, the investigators' aim is to test the hypothesis that trigeminal cardiac reflex associates postoperative myocardial damage in participants undergoing skull base tumor surgery. The investigators will observe the association between trigeminal cardiac reflex and myocardial injury by measuring the concentration of plasma high sensitivity cardiac troponin (hs-cTnT) in participants after skull base tumor surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
476

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 13, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 20, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 9, 2024

Completed
Last Updated

February 14, 2025

Status Verified

February 1, 2025

Enrollment Period

2.3 years

First QC Date

December 13, 2021

Last Update Submit

February 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The incidence of postoperative myocardial injury

    the elevation of plasma high sensitivity cardiac troponin I (hs-cTnI) caused by myocardial ischemia or injury (exclude other causes such as sepsis, pulmonary embolism, atrial fibrillation, etc). The blood samples before and within 24 hours after operation will be collected and measured by Roche's fourth generation hs-cTnI. It is commonly defined as an elevation as any value above the 99th percentile upper reference limit for each specific troponin I assay

    Postoperative 1 day.

Secondary Outcomes (1)

  • The duration time of trigeminal cardiac reflex during skull base tumor surgery.

    The whole skull base tumor surgery procedure.

Study Arms (2)

Postoperative myocardial injury

Other: Trigeminal cardiac reflex

Non postoperative myocardial injury

Other: Non-trigeminal cardiac reflex

Interventions

Trigeminal cardiac reflex occurred during the cerebellopontine angle tumor surgery.

Postoperative myocardial injury

No trigeminal cardiac reflex occurred during the cerebellopontine angle tumor surgery.

Non postoperative myocardial injury

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged more than 18 years old with American Society of Anesthesiology status I to III who will be scheduled to receive elective skull base tumor surgery under general anesthesia. Patients with trigeminal cardiac reflex during surgery will be included in the exposure group while patients without trigeminal cardiac reflex during surgery will be included in the non-exposure group.

You may qualify if:

  • Patients undergoing elective skull base tumor surgery.
  • Age ≥ 18 years old.
  • ASA class I to III.
  • All those who sign the informed consent form.

You may not qualify if:

  • Patients with severe heart disease (including patients with preoperative heart rate \< 50 beats / min, severe arrhythmias, such as premature beats, paroxysmal supraventricular tachycardia, atrial flutter or fibrillation, patients with myocardial ischemia \< 6 months, heart failure, myocarditis, pericarditis or cardiomyopathy).
  • Patients unable to complete preoperative cardiac assessment.
  • Patients with chronic kidney disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tian Tan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100070, China

Location

Study Officials

  • florapym766@163.com Peng, MD,Ph.D

    Beijing Tian Tan Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Deputy chief of Department of Anesthesiology

Study Record Dates

First Submitted

December 13, 2021

First Posted

January 20, 2022

Study Start

July 1, 2022

Primary Completion

October 1, 2024

Study Completion

October 9, 2024

Last Updated

February 14, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations